American Society of Hematology

Last updated
American Society of Hematology
AbbreviationASH
Formation1958
Headquarters2021 L Street NW, Suite 900, Washington, D.C. 20036
Membership
17,000
Official language
English
Staff
110-120
Website hematology.org

The American Society of Hematology (ASH) is a professional organization representing hematologists, founded in 1958. Its annual meeting is held in December of every year and has attracted more than 30,000 attendees. [1] The society publishes the medical journal Blood , the most cited peer-reviewed publication in the field, [2] and Blood Advances, an online, peer-reviewed open-access journal. [3] [4]

Contents

The first official ASH meeting was held in Atlantic City, New Jersey, in April 1958. More than 300 hematologists met together to discuss the key research and clinical issues related to blood and blood diseases. Since the first gathering, ASH has been an important member in the development of hematology as a discipline. For more than six decades, ASH has sponsored its annual meeting. Today, ASH has more than 17,000 members, [4] many of whom have made major advancements in understanding and treating blood diseases.

Annual meeting

Held each year in December, the annual meeting brings together hematologists from around the world to discuss hematology. During the four-day meeting, several educational programs and scientific sessions are held. The annual meeting also features oral and poster presentations that are chosen by peer-reviewers from abstracts submitted prior to the meeting and contain developments in scientific research. Plenary symposia and named lectures on specialized areas of hematology are also presented throughout the meeting program. More than 21,000 clinicians, scientists, and others attend.[ citation needed ]

Partnerships

ASH receives financial support from, and collaborates with, a number of pharmaceutical companies. Notable corporate partners include AstraZeneca, Bayer, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Merck, Pfizer, and Regeneron Pharmaceuticals. [5]

Publications

Related Research Articles

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, sickle cell anemia, blood clots (thrombus), other bleeding disorders, and blood cancers such as leukemia, multiple myeloma, and lymphoma. The laboratory analysis of blood is frequently performed by a medical technologist or medical laboratory scientist.

<span class="mw-page-title-main">American Society for Microbiology</span> American scholarly society focused on microbiology

The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It was founded in 1899. The Society publishes a variety of scientific journals, textbooks, and other educational materials related to microbiology and infectious diseases. ASM organizes annual meetings, as well as workshops and professional development opportunities for its members.

William Dameshek was an American hematologist. He graduated from Harvard College and Harvard Medical School and spent the early part of his career at Beth Israel Hospital. He was the founder of Blood, the prime core clinical journal of hematology, in 1946. He is also credited with describing the concept of myeloproliferative diseases in 1951. In addition, he participated in the first studies of nitrogen mustard in various hematological malignancies, widely considered the first uses of chemotherapy in malignant diseases. Dr Dameshek was also the first one who described chronic lymphocytic leukemia (CLL), a common form of leukemia in adults.

The American Association for Cancer Research (AACR) is the world's oldest and largest professional association related to cancer research. Based in Philadelphia, the AACR focuses on all aspects of cancer research, including basic, clinical, and translational research into the etiology, prevention, diagnosis, and treatment of cancer. Founded in 1907 by 11 physicians and scientists, the organization now has more than 52,000 members in 130 countries and territories. The mission of the AACR is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.

The Society for Hematology and Stem Cells is a learned society which deals with hematology, the study of the blood system and its diseases, including those caused by exposure to nuclear radiation. It was founded in 1950, and held its first official meeting in Milwaukee in 1972. Its mission statement is: "To promote the scientific knowledge and clinical application of basic hematology, immunology, stem cell research, cell and gene therapy and related aspects of research through publications, discussions, scientific meetings and the support of young investigators."

AACC is a global scientific society dedicated to clinical laboratory science and its application to healthcare. AACC's current president is Carmen Wiley, PhD, and the association headquarters are located in Washington, D.C..

The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.

The European Academy of Allergy and Clinical Immunology (EAACI) is a non-profit organisation for European clinicians, researchers and allied health professionals in the field of allergy and clinical immunology, covering asthma, rhinitis, eczema and occupational allergy, food and drug allergy, severe anaphylactic reactions, autoimmune disorders, and immunodeficiencies.

<i>Haematologica</i> Academic journal

Haematologica is a monthly, peer reviewed, scientific journal, published by the Ferrata Storti Foundation. The editor in chief is Dr. Jacob M. Rowe. The focus of Haematologica is all topics related to experimental and clinical hematology, which results in a multidisciplinary scope. The National Library of Medicine ID number is 0417435.

The European Association for the Study of the Liver (EASL) is a European professional association for those researching liver disease.

The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.

<span class="mw-page-title-main">Binaytara Foundation</span> U.S. nonprofit organization

The Binaytara Foundation (BTF) was established in 2007 by Dr. Binay Shah and wife Tara Shah with the goal of promoting health and education in underprivileged societies. The BTF is a Washington State nonprofit organization exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code. BTF has founded multiple programs in underdeveloped and developing countries to improve access to healthcare. Recent accomplishments include building a 25-bed cancer hospital in Nepal in 2018 and breaking ground on their new 200-bed facility in 2022.

The International Society for Laboratory Hematology (ISLH) is a non-profit organisation founded in 1992. Its purpose is to provide a forum for dissemination of new ideas and information related to the field of laboratory hematology.

Jyoti Bhusan Chatterjea (1919–1972) was an Indian hematologist, medical academic and the director of Calcutta School of Tropical Medicine, He was known for his hematological and clinical studies of Hemoglobin E/β-thalassaemia and was an elected fellow of the National Academy of Medical Sciences, and the Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 1966.

<span class="mw-page-title-main">Musa Mirmammad oglu Abdullayev</span> Azerbaijani medical doctor (1927-1979)

Musa Mirmammad oglu Abdullayev (27 November 1927, Masallı district, Azerbaijan SSR, USSR — 8 August 1979, Baku, Azerbaijan SSR, USSR) — Prominent hematologist of Azerbaijan, doctor of medicine, professor, philologist-translator. He was one of the eight members of the anti-Soviet nationalist student-youth political organization "Lightning" (İldırım), formed for the independence of Azerbaijan within 1942-1944.

<span class="mw-page-title-main">Martin Körbling</span> German professor of medicine

Martin Körbling is a German-American internist and hematologist, university professor, medical researcher and pioneer of blood stem cell transplantation.

Stephanie J. Lee is an American haematologist and physician scientist who is Professor and Associate Director at the Fred Hutchinson Cancer Research Center. Lee works to improve the lives of blood stem cell transplant and bone marrow patients by better understanding the chronic form of graft-versus-host disease. Lee is the former President of the American Society of Hematology.

<span class="mw-page-title-main">Bob Löwenberg</span>

Bob Löwenberg is a clinical hematologist/investigator. He is Professor of Hematology at Erasmus University Rotterdam.

Cynthia Dunbar is an American scientist and hematologist at the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). She is the Branch Chief of the Translational Stem Cell Biology Branch.

<span class="mw-page-title-main">Julie Panepinto</span>

Julie Ann Panepinto is an American pediatric hematologist-oncologist and physician-scientist. She specializes in health outcomes research and sickle cell disease. Panepinto became the acting director of the division of blood diseases and resources at the National Heart, Lung, and Blood Institute in 2022. She was a professor of pediatrics and hematology at the Medical College of Wisconsin.

References

  1. Caffrey, Mary. "ASH 2021 Plans a Hybrid Format - With COVID-19, CAR T, and Health Equity on the Agenda". AJMC. The American Journal of Managed Care. Retrieved April 28, 2022.
  2. Berliner, Nancy. "Blood". Elsevier. Elsevier. Retrieved April 28, 2022.
  3. Bollard, Catherine. "Blood Advances". Elsevier. Elsevier. Retrieved April 28, 2022.
  4. 1 2 American Society of Hematology. "About ASH". Archived from the original on 2001-06-14.
  5. "Corporate Support". American Society of Hematology. Archived from the original on 2022-06-10. Retrieved 2022-06-10.